Burnie Academy Academy
An honest look at weight-loss money and GLP-1 medicines

An honest look at weight-loss money and GLP-1 medicines

The diet industry has profited from weight loss and regain for decades. GLP-1 medicines are real and tested, but the money side still matters.

13 Jul 2026 · Burnie Academy
glp-1 weight-loss-industry india honest

For decades, companies have made money from people trying to lose weight. Shakes, pills, gadgets, plans — many sold hope, not results. Now GLP-1 medicines are here, and they actually work. But money is still part of the story. Let us look at it honestly, without fear and without hype.

The diet industry is old and big

The diet industry sells plans, shakes, teas, creams, and gadgets. Many promise easy weight loss. Most have no real trials behind them. People lose some weight, then regain it. Doctors call this weight cycling, or yo-yo dieting. A big government review found the evidence on weight cycling is mixed. It said obese people should still try to lose weight, but should commit to lifelong changes. The key lesson is simple. Quick fixes rarely last. That is why the diet industry keeps selling new ones.

Old diet products vs GLP-1 medicines

Diet shakes and teas
Sold for profit. No big trials. No FDA check. Weight usually returns.
Slimming gadgets (belts, wraps)
No proof they work. Money-back is rare. They target your worry, not your fat.
Banned diet pills (fen-phen, sibutramine)
FDA pulled them. They hurt hearts. Real lesson: some diet drugs were dangerous.
GLP-1 medicines (semaglutide and similar)
FDA-approved. Tested in big trials. Real weight loss. But also high prices and big profits.

GLP-1 is just the latest diet-industry scam.

mostly false

Mostly false. GLP-1 medicines are real medicine. They are FDA-approved and were tested in large trials. That makes them different from shakes and gadgets, which have no real proof. But the money worries are real. GLP-1 is now a huge profit centre. In 2025 Novo Nordisk's total sales were about DKK 309 billion (around $47 billion). In India, generics are changing the picture fast. In March 2026, Glenmark launched a generic semaglutide for about Rs 325 to 440 per week, while Novo Nordisk's branded starting doses cost Rs 8,800 to 10,850 per month. So GLP-1 is not a scam. It is real medicine that also makes real money. Both things are true at once.

The food industry is watching too

Some people worry the food industry secretly funds anti-GLP-1 messages. Be careful here. We could not find solid proof of that, so we will not claim it. What we did find is reporting that food companies are adapting, not panicking. One food-industry boss said GLP-1 is a threat but manageable. Some snack makers even sell 'GLP-1-friendly' foods. That is normal business, not a conspiracy. Stay sceptical of any secret plot story that has no named source.

How to think about money and weight medicine

The bottom line

GLP-1 is real medicine, not a scam. It was tested and approved, unlike old shakes and banned pills. But it is also a big money machine, with high prices and long-term use. Stay clear-eyed. Trust the science, ask about cost, and talk to your doctor before any change.

Track your food the honest way

Burnie helps you see your estimated calorie deficit with familiar Indian foods — no fake precision, no guilt trips.

Get Burnie on the App Store

Android public availability is being expanded.